Akhil Abraham Saji, MD

Akhil Abraham Saji, MD, is a urologist specializing in minimally invasive surgery and urologic oncology with an interest in technology-driven innovation within health care.

Articles by Akhil Abraham Saji, MD

Akhil Abraham Saji, MDLocalized Prostate Cancer | September 5, 2023
The da Vinci Single Port platform allows robot-assisted surgical procedures with the same precision as multiport techniques.
Read More
Akhil Abraham Saji, MDProstate Cancer | September 5, 2023
Increasing competition in robot-assisted surgical platform production will increase accessibility for patients everywhere.
Akhil Abraham Saji, MDNext-Generation Imaging | July 31, 2023
PSMA PET imaging is a leap forward in the fight to cure prostate cancer, especially as theranostic capabilities expand.
Akhil Abraham Saji, MDLocalized Prostate Cancer | July 31, 2023
What role can artificial intelligence play in the diagnosis and management of prostate cancer utilizing MRI?
Akhil Abraham Saji, MDAUA 2023 | May 31, 2023
One might assume that the AUA meeting is geared toward practicing urologists, but it is also crucial for urologic trainees.
Akhil Abraham Saji, MDLocalized Prostate Cancer | May 30, 2023
The postsurgical treatment of functional outcomes such as UI and ED after SRP remains a challenge for all urologists.
Akhil Abraham Saji, MDNon-Muscle Invasive Urothelial Carcinoma | May 30, 2023
FDA approval of Adstiladrin for use in BCG-unresponsive NMIBC expands the armamentarium for treatment of high-risk NMIBC.
David Ambinder, MDAUA 2023 | May 2, 2023
Drs. David Ambinder and Akhil Saji highlight the importance of attending the AUA meeting as urology residents.
Akhil Abraham Saji, MDNon-Muscle Invasive Urothelial Carcinoma | May 1, 2023
NMIBC-associated costs vary widely across types of treatments utilized, health systems, and regions of the country.
Akhil Abraham Saji, MDMuscle Invasive Urothelial Carcinoma | May 1, 2023
The minimally invasive options available to patients diagnosed with muscle-invasive disease of urothelial origin are limited.
Akhil Abraham Saji, MDProstate Cancer | March 31, 2023
This review highlights the existing research regarding the financial toxicity of advanced prostate cancer.
Akhil Abraham Saji, MDAUA 2023 | March 30, 2023
This review highlights the upcoming plenary sessions of importance in prostate, bladder, kidney, and testicular cancer.
Akhil Abraham Saji, MDLocalized Renal Cell Carcinoma | March 30, 2023
AUA guidelines for localized RCC have thermal ablation as an alternative modality. EAU guidelines are conflicting.
Akhil Abraham Saji, MDProstate Cancer | March 10, 2023
Mutahar Ahmed, MD, discusses the history and current applications of single-port robotic surgery in prostate cancer.
Akhil Abraham Saji, MDLocalized Prostate Cancer | February 28, 2023
This review highlights the research on the costs related to the treatment of localized PC and the associated outcomes.
Akhil Abraham Saji, MDNon-Muscle Invasive Urothelial Carcinoma | February 24, 2023
BCG plus nogapendekin alfa inbakicept may offer an enhanced treatment option for patients with high-risk NMIBC.
Akhil Abraham Saji, MDProstate Cancer | January 13, 2023
A review of the GÖTEBORG-2 trial and the current recommendations for utilizing mpMRI in prostate cancer screening, ...
Akhil Abraham Saji, MDUrothelial Carcinoma | January 13, 2023
An investigation and review of both studies regarding their differences, similarities, and conclusions.
Akhil Abraham Saji, MDProstate Cancer | January 13, 2023
The evidence regarding bisphosphate and denosumab therapy and the impact that bone-protective agents can have on patients.
Akhil Abraham Saji, MDJournal | December 19, 2022
At the ASTRO 2022 meeting, several authors presented abstracts on postprostatectomy radiation that are worth reviewing.